Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowMike Blue, President and CEO of HistoSonics, sits down with Nasdaq’s Kristina Ayanian to discuss how histotripsy is redefining cancer treatment, the breakthrough Edison® System, and what these milestones mean for global adoption and the future of non-invasive surgery.